The major
drivers of the market are the rising prevalence of cardiovascular diseases and
reduced occupational hazards for cardiologists. These systems are medical
robots that work through a joy stick or a remote to perform various diagnostic
and therapeutic procedures, such as the stent implantation, myocardial biopsy,
ablation, and coronary angiogram, among others.
The robotic catheter systems market is categorized into Middle East
& Africa, Latin America, Asia-Pacific, Europe, and North America based on
region. In 2018, the highest revenue generator in the market was North America,
and in the forecast period as well, it would continue to dominate the market,
in terms of revenue. The major driving
factors of the regional market are the high adoption of these systems for
cardiovascular diagnostic and therapeutic procedures in hospitals and clinics
and the large presence of key manufacturers.
The robotic
catheter systems market is witnessing the trend of digitization of instruments,
which has been a key factor in the evolution of integrated and automated
cardiovascular interventional labs. The advancements in the robotic technology
are taking place rapidly, which, in turn, is helping hospitals cut down on
catheterization lab costs, particularly in remote areas. The operational
efficiency of cath labs has massively improved due to the commercialization of
such systems. Even though these systems are
pretty expensive, they are being heavily deployed owing to the advantages they
offer over conventional catheterization procedures.
Access Report Summary - Robotic Catheter Systems Market Segmentation Analysis
With the
technological advancements, the robotic catheter systems market would witness
remarkable growth due to the extensive testing of these systems in the clinical
trials. Catheterized cardiovascular procedures, such as catheter ablation, are
popularly used in modern medicine, but robot-assisted catheterized procedures
have not become as popular as their conventional counterparts due to the
scarcity of skilled professionals. Companies, such as CorPath, Amigo, Sensei,
and Niobe are commercializing robot catheterization systems, which may
contribute in the demand for training people for operating the technology,
thereby making them popular among patients and surgeons.
Hence, the
market for robotic catheter systems is set to advance in the forecast period as
the requirement for safer technologies for carrying out cardiovascular
procedures is rising.
